-
公开(公告)号：US11918594B2
公开(公告)日：2024-03-05
申请号：US17956139
申请日：2022-09-29
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
CPC classification number: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US11858895B2
公开(公告)日：2024-01-02
申请号：US17946457
申请日：2022-09-16
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.
-
公开(公告)号：US11752130B2
公开(公告)日：2023-09-12
申请号：US17951530
申请日：2022-09-23
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/404 , A61P25/18 , C07D209/32 , C07D209/16 , C07D209/30
CPC classification number: A61K31/404 , A61P25/18 , C07D209/16 , C07D209/30 , C07D209/32
Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
-
公开(公告)号：US20250129036A1
公开(公告)日：2025-04-24
申请号：US18982705
申请日：2024-12-16
Applicant: Enveric Biosciences Canada Inc.
Inventor： Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Jillian M. Hagel , Peter J. Facchini
IPC: C07D317/58 , A61P25/00 , C07D319/18 , C07D405/06
Abstract: Disclosed are novel fused mescaline derivative compounds, notably C1-substituted isopropylamine fused heterocyclic mescaline derivatives, including C1-substituted isopropylamine fused dioxolane and fused dioxane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
-
公开(公告)号：US20250057861A1
公开(公告)日：2025-02-20
申请号：US18909368
申请日：2024-10-08
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini
IPC: A61K31/675 , A61K31/4045 , C12N9/02 , C12N9/10 , C12N9/12 , C12N15/52 , C12P17/10
Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
-
Patent Agency Ranking
公开(公告)号：US12187679B2
公开(公告)日：2025-01-07
申请号：US17903103
申请日：2022-09-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
Abstract: Disclosed are novel hydroxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced synthetically or biosynthetically.
-
公开(公告)号：US12065404B2
公开(公告)日：2024-08-20
申请号：US17886075
申请日：2022-08-11
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
IPC: C07D209/16 , A61K31/4045 , A61P25/00 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
CPC classification number: C07D209/16 , A61K31/4045 , A61P25/00 , C07D209/20 , C07D401/12 , C07D403/12 , C07D405/12
Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
公开(公告)号：US11998557B2
公开(公告)日：2024-06-04
申请号：US17903080
申请日：2022-09-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini
IPC: A61K31/675 , A61K31/4045 , C12N9/02 , C12N9/10 , C12N9/12 , C12N15/52 , C12P17/10
CPC classification number: A61K31/675 , A61K31/4045 , C12N9/0083 , C12N9/1007 , C12N9/1205 , C12N15/52 , C12P17/10
Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
-
公开(公告)号：US20240116907A1
公开(公告)日：2024-04-11
申请号：US18230332
申请日：2023-08-04
Applicant: Enveric Biosciences Canada Inc.
Inventor： Peter J. Facchini , Jillian M. Hagel , Chang-Chun Ling , Charlie Cai , David James Press , Glynnis Elizabeth Jensen , Jessica Bik-Jing Lee , Kaveh Matinkhoo
IPC: C07D407/12 , C07D317/58 , C07D405/06 , C07D405/12
CPC classification number: C07D407/12 , C07D317/58 , C07D405/06 , C07D405/12
Abstract: Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
-
公开(公告)号：US20230357145A1
公开(公告)日：2023-11-09
申请号：US18218216
申请日：2023-07-05
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
-
-
-
-
-
-
-
-
Search Results
46
records
(took 0.015 seconds)
